| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 8 | |
| #2 | Australia | 6 | |
| #3 | United States | 5 | |
| #4 | Canada | 2 | |
| #5 | EPO (European Patent Office) | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Measurement | |
| #5 | Macromolecular chemistry and polymers | |
| #6 | Environmental technology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Yokota Tomoyuki | 13 |
| #2 | Shigeta Shiro | 12 |
| #3 | Baba Masanori | 9 |
| #4 | Hanasaki Yasuaki | 7 |
| #5 | Sudo Kenji | 7 |
| #6 | Fujiwara Masatoshi | 7 |
| #7 | Watanabe Hiroyuki | 7 |
| #8 | Ijichi Katsushi | 7 |
| #9 | Takayama Hiromitsu | 5 |
| #10 | Katsuura Kimio | 5 |
| Publication | Filing date | Title |
|---|---|---|
| WO9943690A1 | L-4'-arabinofuranonucleoside compound and medicine composition comprising the same | |
| WO9719103A1 | Novel synthetic substrate for activity assay having chromophore or fluorochromophore active against hepatitis c virus ns3 protease | |
| WO9708194A1 | Novel fluorescent substrate for assaying activity of hepatitis c virus ns3 serine protease | |
| AU3533095A | Arylthiadiazole derivative and antiviral agent containing the same |